We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group Inc. (CME) - free report >>
Kaman Corporation (KAMN) - free report >>
Amicus Therapeutics, Inc. (FOLD) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 31st
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Amicus Therapeutics, Inc. (FOLD - Free Report) is a biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 0.9% downward over the last 30 days.
CME Group Inc. (CME - Free Report) is an operator of contract markets for the trading of futures and options on futures contracts. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.
Haynes International, Inc. (HAYN - Free Report) is a manufacturer and distributor of nickel and cobalt-based alloys in sheet, coil, and plate forms. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Independent Bank Corp. (INDB - Free Report) is the bank holding company for Rockland Trust Company. The Zacks Consensus Estimate for its current year earnings has been revised 6.2% downward over the last 30 days.
Kaman Corporation (KAMN - Free Report) operates in the aerospace, medical, and industrial markets. The Zacks Consensus Estimate for its current year earnings has been revised 22.5% downward over the last 30 days.
View the entire Zacks Rank #5 List.